U-Chart Analysis:KISSEI PHARMACEUTICAL CO.,LTD.:4547

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KISSEI PHARMACEUTICAL CO.,LTD. Go to web site 4547 Medicals 東証プライム March 1, 2000 1988.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2025年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 25,169 22,894 25,893 30,013 20,456
Other Current AssetsHelp 81,811 81,657 74,748 69,329 72,509
Tangible Fixed AssetsHelp 27,069 24,861 24,579 24,074 24,290
Intangible Fixed AssetHelp 1,652 1,683 1,507 1,569 1,640
Investments and OthersHelp 108,358 129,592 94,164 112,793 149,966
Total AssetsHelp 244,059 260,929 221,200 238,087 268,861
Total Current LiabilitiesHelp 35,055 40,664 26,983 36,474 49,546
Total Long-term LiabilitiesHelp - 236 317 227 0
Shareholder's EquityHelp 209,004 220,029 193,900 201,386 219,315
Total LiabilitiesHelp 244,059 260,929 221,200 238,087 268,861

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2025年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 88,330 75,579 67,493 65,381 69,044
Total Sales 88,330 75,579 67,493 65,381 69,044
Cost of SalesHelp 44,265 38,238 35,118 34,143 36,321
Other Costs and RevenueHelp 32,103 26,179 21,846 18,316 27,438
Total CostsHelp 76,368 64,417 56,964 52,459 63,759
Net RevenueHelp 44,065 37,341 32,375 31,238 32,723
Earnings Before TaxHelp 15,610 14,449 13,680 16,507 7,476
Net IncomeHelp 11,962 11,162 10,529 12,922 5,285
Net Income 11,962 11,162 10,529 12,922 5,285

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2025年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 6,617 -1,678 -6,680 1,533 -2,543
Investing Cash Flow(ICF)Help 4,952 8,690 6,001 10,776 -9,329
Financing Cash FlowHelp -9,325 -10,006 -3,420 -2,756 -4,000
Exchange Difference of Cash and Cash EquivalentsHelp 27 -3 -21 4 0
Net Increase and Decrease in Cash and Cash Equivalentsn 2,271 -2,997 -4,120 9,557 -15,872

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KISSEI PHARMACEUTICAL CO.,LTD.
Azbil Corporation
SENKO Group Holdings Co.,Ltd.
NIPPON CHUTETSUKAN K.K.
Hokuhoku Financial Group, Inc.

Company where related level is highHelp

K Pharma,Inc.
SANTEN PHARMACEUTICAL CO.,LTD.
BrightPath Biotherapeutics Co., Ltd.
RaQualia Pharma Inc.
CellSource Co., Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
CHUGAI PHARMACEUTICAL CO., LTD.
NANO MRNA Co., Ltd.
Carna Biosciences,Inc.
Heartseed